| Primary |
| Arthritis |
17.9% |
| Headache |
16.9% |
| Back Pain |
15.5% |
| Analgesic Therapy |
12.1% |
| Pain |
9.6% |
| Migraine |
5.7% |
| Toothache |
4.5% |
| Arthralgia |
3.6% |
| Pain In Extremity |
2.7% |
| Myalgia |
2.5% |
| Ischaemic Heart Disease Prophylaxis |
1.7% |
| Dysmenorrhoea |
1.3% |
| Inflammation |
1.3% |
| Musculoskeletal Pain |
1.0% |
| Pyrexia |
0.9% |
| Hypertension |
0.6% |
| Neck Pain |
0.6% |
| Sciatica |
0.6% |
| Muscle Spasms |
0.5% |
| Muscle Strain |
0.5% |
|
| Drug Ineffective |
47.0% |
| Incorrect Drug Administration Duration |
15.4% |
| Extra Dose Administered |
6.8% |
| Incorrect Dose Administered |
5.8% |
| Off Label Use |
4.8% |
| Dyspepsia |
3.4% |
| Therapeutic Response Unexpected |
2.2% |
| Overdose |
1.9% |
| Pre-existing Condition Improved |
1.7% |
| Abdominal Discomfort |
1.6% |
| Urticaria |
1.6% |
| Somnolence |
1.3% |
| Nausea |
1.0% |
| Vomiting |
1.0% |
| Inappropriate Schedule Of Drug Administration |
0.9% |
| Rash |
0.8% |
| Drug Hypersensitivity |
0.7% |
| Gastric Disorder |
0.7% |
| Insomnia |
0.7% |
| Swelling Face |
0.7% |
|
| Secondary |
| Arthritis |
21.7% |
| Back Pain |
15.5% |
| Analgesic Therapy |
9.0% |
| Headache |
8.7% |
| Pain |
8.5% |
| Pain In Extremity |
5.3% |
| Arthralgia |
5.0% |
| Migraine |
3.3% |
| Pain Management |
3.1% |
| Inflammation |
2.9% |
| Ischaemic Heart Disease Prophylaxis |
2.8% |
| Myalgia |
2.8% |
| Pyrexia |
2.2% |
| Neck Pain |
2.0% |
| Ear Pain |
1.8% |
| Dysmenorrhoea |
1.1% |
| Muscle Strain |
1.1% |
| Sinus Headache |
1.1% |
| Toothache |
1.1% |
| Chills |
0.9% |
|
| Drug Ineffective |
33.6% |
| Incorrect Drug Administration Duration |
22.8% |
| Extra Dose Administered |
10.4% |
| Off Label Use |
9.2% |
| Incorrect Dose Administered |
6.0% |
| Nausea |
2.0% |
| Rectal Haemorrhage |
2.0% |
| Urticaria |
2.0% |
| Overdose |
1.6% |
| Vomiting |
1.6% |
| Palpitations |
1.2% |
| Rash Generalised |
1.2% |
| Drug Hypersensitivity |
0.8% |
| Feeling Abnormal |
0.8% |
| Gastric Ulcer |
0.8% |
| Insomnia |
0.8% |
| Pruritus |
0.8% |
| Rash Macular |
0.8% |
| Renal Failure |
0.8% |
| Renal Failure Chronic |
0.8% |
|
| Concomitant |
| Premedication |
37.5% |
| Multiple Sclerosis |
25.0% |
| Relapsing-remitting Multiple Sclerosis |
25.0% |
| Gait Disturbance |
12.5% |
|
| Drug Ineffective |
12.5% |
| Incorrect Drug Administration Duration |
12.5% |
| Lower Respiratory Tract Infection |
12.5% |
| Muscular Weakness |
12.5% |
| Night Sweats |
12.5% |
| Skin Discolouration |
12.5% |
| Somnolence |
12.5% |
| Urinary Tract Infection |
12.5% |
|
| Interacting |
| Ischaemic Heart Disease Prophylaxis |
33.3% |
| Product Used For Unknown Indication |
16.7% |
| Bladder Cancer |
8.3% |
| Deep Vein Thrombosis |
8.3% |
| Embolism Venous |
8.3% |
| Neuralgia |
8.3% |
| Pulmonary Embolism |
8.3% |
| Testicular Disorder |
8.3% |
|
| Labelled Drug-drug Interaction Medication Error |
33.3% |
| Rectal Haemorrhage |
33.3% |
| Thrombocytopenia |
33.3% |
|
